MOG-specific T cell response amplified in para- and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease

J Neuroimmunol. 2023 Sep 15:382:578143. doi: 10.1016/j.jneuroim.2023.578143. Epub 2023 Jul 5.

Abstract

We describe clinical characteristics and deep immunophenotypes in two patients with myelin-oligodendrocyte-glycoprotein (MOG)-antibody-associated-disease after COVID-19. The para-COVID case was a 74-year-old man who developed optic neuritis two days after COVID-19. Immunological assays revealed reduced absolute CD8+ T- and B-cell counts with increased frequency of NK cells. Post-COVID case was a 63-year-old man with optic neuritis six months after COVID-19, a frequency of CD8+ T-cells was elevated with a relatively low fraction of naïve and a high fraction of effector memory CD8+ T-cells. There was increased frequency of CD8+CD38+HLA-DR+ T-cells in the para-COVID case; interestingly, CD4+CD38+HLA-DR+ T cell frequency was increased in the post-COVID case. Both had increased SARS-CoV-2-specific and MOG-specific T-cell responses.

Keywords: COVID-19; MOGAD; Myelin oligodendrocyte glycoprotein antibody-associated disease; Optic neuritis; SAR-CoV-2.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Autoantibodies
  • CD8-Positive T-Lymphocytes / immunology
  • COVID-19* / complications
  • COVID-19* / immunology
  • Humans
  • Male
  • Middle Aged
  • Myelin-Oligodendrocyte Glycoprotein* / immunology
  • Optic Neuritis* / etiology
  • Optic Neuritis* / immunology
  • SARS-CoV-2

Substances

  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein